EyePoint, Inc. (EYPT) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Eyepoint, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.137 Good morning. My name is Antoine and I will be your conference operator today. 00:00:05.137 -- 00:00:10.823 At this time, I would like to welcome everyone to the iPoint third quarter 2025 financial 00:00:10.823 -- 00:00:15.088 results and recent corporate developments conference call. 00:00:15.088 -- 00:00:19.293 There will be a question and answer session to follow at the completion of the prepared 00:00:19.293 -- 00:00:20.934 remarks. 00:00:20.934 -- 00:00:25.480 Please be advised that this call is being recorded at the company's request. 00:00:25.480 -- 00:00:28.280 I would now like to turn the call over to George Elston. 00:00:28.280 -- 00:00:32.604 Executive Vice President and Chief Financial Officer of iPoint. 00:00:32.604 -- 00:00:35.004 Please go ahead. 00:00:35.307 -- 00:00:39.831 Thank you, and thank you all for joining us on today's conference call to discuss iPoint's 00:00:39.831 -- 00:00:45.036 third quarter 2025 financial results in recent corporate developments. 00:00:45.036 -- 00:00:50.161 With me today is Dr. Jay Duker, President and Chief Executive Officer of iPoint. 00:00:50.161 -- 00:00:54.385 Jay will begin with a review of recent corporate updates and discuss our clinical programs 00:00:54.385 -- 00:00:59.459 for door review in wet AMD and DME. I will close with commentary on the third 00:00:59.459 -- 00:01:04.304 quarter 2025 financial results. We will then open the call for your questions where we 00:01:04.304 -- 00:01:08.969 will be joined by Dr. Ramiro Ribeiro, our chief medical officer. 00:01:08.969 -- 00:01:13.313 Earlier this morning, we issued a press release detailing our financial results and recent 00:01:13.313 -- 00:01:17.717 corporate developments. A copy of this release can be found in the invest...